FLUIMEDIX ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About FLUIMEDIX ApS
FLUIMEDIX ApS (CVR number: 27021689) is a company from ALBERTSLUND. The company recorded a gross profit of 244.2 kDKK in 2023. The operating profit was -111.2 kDKK, while net earnings were -80.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -19.7 %, which can be considered poor and Return on Equity (ROE) was -23.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 44.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. FLUIMEDIX ApS's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | - 407.89 | - 181.69 | -1.25 | -89.33 | 244.18 |
EBIT | -1 237.88 | - 325.36 | - 353.52 | - 459.65 | - 111.16 |
Net earnings | - 970.31 | - 254.22 | - 278.95 | - 363.53 | -80.66 |
Shareholders equity total | 680.12 | 1 025.91 | 746.96 | 383.43 | 302.77 |
Balance sheet total (assets) | 715.80 | 1 150.88 | 793.34 | 445.10 | 674.23 |
Net debt | -2.77 | - 507.27 | - 440.34 | - 173.27 | - 324.39 |
Profitability | |||||
EBIT-% | |||||
ROA | -27.3 % | -34.9 % | -36.4 % | -74.2 % | -19.7 % |
ROE | -72.6 % | -29.8 % | -31.5 % | -64.3 % | -23.5 % |
ROI | -28.5 % | -37.1 % | -38.3 % | -77.7 % | -29.8 % |
Economic value added (EVA) | - 592.73 | - 287.67 | - 274.95 | - 374.30 | -89.71 |
Solvency | |||||
Equity ratio | 95.0 % | 89.1 % | 94.2 % | 86.1 % | 44.9 % |
Gearing | 4.9 % | 3.3 % | 7.4 % | 8.9 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 12.6 | 7.6 | 13.9 | 6.0 | 1.8 |
Current ratio | 12.6 | 7.6 | 13.9 | 6.0 | 1.8 |
Cash and cash equivalents | 2.77 | 557.27 | 465.35 | 201.49 | 351.35 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BBB | BB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.